Lim, So-Young
Macheleidt, Iris
Dalvi, Priya
Schäfer, Stephan C.
Kerick, Martin
Ozretić, Luka
Ortiz-Cuaran, Sandra
George, Julie
Merkelbach-Bruse, Sabine
Wolf, Jürgen
Timmermann, Bernd
Thomas, Roman K.
Schweiger, Michal R.
Buettner, Reinhard
Odenthal, Margarete
Article History
Received: 10 February 2017
Accepted: 24 July 2017
First Online: 31 August 2017
Change Date: 1 November 2018
Change Type: Correction
Change Details: A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has been fixed in the paper.
Competing Interests
: R.K.T. is a consultant of NEO New Oncology GmbH and received honoraria from AstraZeneca, Bayer, NEO New Oncology GmbH, Boehringer Ingelheim, Clovis Oncology, Daiichi-Sankyo, Eli Lilly, Johnson & Johnson, Merck KGaA, MSD, Puma, Roche and Sanofi.